重大胎儿先天性心脏病中的妊娠丢失:发生率、危险因素与发生时机
基于犹他州出生缺陷网络1997–2018年数据的回顾性人群队列研究,3120例重大胎儿先天性心脏病中妊娠丢失发生率为5.3%,中位孕周27.3周;整体调整后妊娠丢失风险5.3%(95%CI 3.7-7.6%),孤立性先心病为1.4%(95%CI 0.9-2.3%),风险随先心病类型及是否合并其他胎儿诊断而异。
要点
- 重大胎儿先心病妊娠丢失率5.3%,中位发生孕周27.3周。
- 二尖瓣狭窄者妊娠丢失发生率最高(<13.5%),其次为左心发育不良综合征(10.7%)。
- 合并其他胎儿诊断者妊娠丢失风险显著增高(aOR 6.3,95%CI 4.1-10)。
核心结论
- 重大胎儿先心病妊娠丢失风险高于一般人群(调整风险5.3% vs 一般人群0.6%,调整风险比9.0,95%CI 6.0-13.0),且随先心病类型及是否合并其他胎儿诊断而变化。
研究设计与样本
- 回顾性、人群水平队列研究,经犹他州出生缺陷网络(UBDN)识别1997–2018年重大先心病胎儿及婴儿,排除终止妊娠131例后纳入3120例。
诊断标准与关键数值
- 总体先心病人群调整后妊娠丢失风险5.3%(95%CI 3.7-7.6%),基于一般人群风险0.6%的调整风险比为9.0(95%CI 6.0-13.0)。
- 孤立性先心病调整后妊娠丢失风险1.4%(95%CI 0.9-2.3%),调整风险比2.0(95%CI 1.0-6.0)。
- 妊娠丢失观察发生率:二尖瓣狭窄<13.5%,左心发育不良综合征10.7%,右室双出口伴大血管关系正常或未特指10.5%,Ebstein畸形9.9%。
临床应用与阅片要点
- 合并胎儿水肿者妊娠丢失风险显著增高(aOR 6.7,95%CI 4.3-10.5),阅片时需关注水肿征象。
- 产前诊断亚组中,房室瓣反流≥中度(aOR 3.6,95%CI 1.3-8.8)及心室功能障碍(aOR 3.8,95%CI 1.2-11.1)与妊娠丢失相关。
- 左心发育不良综合征及变异型(aOR 3.0,95%CI 1.7-5.3)与其他单心室(aOR 2.4,95%CI 1.1-4.9)与妊娠丢失相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Fetuses with congenital heart disease (CHD) are at increased risk of pregnancy loss compared with the general population. We aimed to assess the incidence, timing and risk factors of pregnancy loss in cases with major fetal CHD, overall and according to cardiac diagnosis.
METHODS: This was a retrospective, population-level cohort study of fetuses and infants diagnosed with major CHD between 1997 and 2018 identified by the Utah Birth Defect Network (UBDN), excluding cases with termination of pregnancy and minor cardiovascular diagnoses (e.g. isolated aortic/pulmonary pathology and isolated septal defects). The incidence and timing of pregnancy loss were recorded, overall and according to CHD diagnosis, with further stratification based on presence of isolated CHD vs additional fetal diagnosis (genetic diagnosis and/or extracardiac malformation). Adjusted risk of pregnancy loss was calculated and risk factors were assessed using multivariable models for the overall cohort and prenatal diagnosis subgroup.
RESULTS: Of 9351 UBDN cases with a cardiovascular code, 3251 cases with major CHD were identified, resulting in a study cohort of 3120 following exclusion of cases with pregnancy termination (n = 131). There were 2956 (94.7%) live births and 164 (5.3%) cases of pregnancy loss, which occurred at a median gestational age of 27.3 weeks. Of study cases, 1848 (59.2%) had isolated CHD and 1272 (40.8%) had an additional fetal diagnosis, including 736 (57.9%) with a genetic diagnosis and 536 (42.1%) with an extracardiac malformation. The observed incidence of pregnancy loss was highest in the presence of mitral stenosis (< 13.5%), hypoplastic left heart syndrome (HLHS) (10.7%), double-outlet right ventricle with normally related great vessels or not otherwise specified (10.5%) and Ebstein's anomaly (9.9%). The adjusted risk of pregnancy loss was 5.3% (95% CI, 3.7-7.6%) in the overall CHD population and 1.4% (95% CI, 0.9-2.3%) in cases with isolated CHD (adjusted risk ratio, 9.0 (95% CI, 6.0-13.0) and 2.0 (95% CI, 1.0-6.0), respectively, based on the general population risk of 0.6%). On multivariable analysis, variables associated with pregnancy loss in the overall CHD population included female fetal sex (adjusted odds ratio (aOR), 1.6 (95% CI, 1.1-2.3)), Hispanic ethnicity (aOR, 1.6 (95% CI, 1.0-2.5)), hydrops (aOR, 6.7 (95% CI, 4.3-10.5)) and additional fetal diagnosis (aOR, 6.3 (95% CI, 4.1-10)). On multivariable analysis of the prenatal diagnosis subgroup, years of maternal education (aOR, 1.2 (95% CI, 1.0-1.4)), presence of an additional fetal diagnosis (aOR, 2.7 (95% CI, 1.4-5.6)), atrioventricular valve regurgitation ≥ moderate (aOR, 3.6 (95% CI, 1.3-8.8)) and ventricular dysfunction (aOR, 3.8 (95% CI, 1.2-11.1)) were associated with pregnancy loss. Diagnostic groups associated with pregnancy loss were HLHS and variants (aOR, 3.0 (95% CI, 1.7-5.3)), other single ventricles (aOR, 2.4 (95% CI, 1.1-4.9)) and other (aOR, 0.1 (95% CI, 0-0.97)). Time-to-pregnancy-loss analysis demonstrated a steeper survival curve for cases with an additional fetal diagnosis, indicating a higher rate of pregnancy loss compared to cases with isolated CHD (P < 0.0001).
CONCLUSIONS: The risk of pregnancy loss is higher in cases with major fetal CHD compared with the general population and varies according to CHD type and presence of additional fetal diagnoses. Improved understanding of the incidence, risk factors and timing of pregnancy loss in CHD cases should inform patient counseling, antenatal surveillance and delivery planning. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Jepson BM, Metz TD, Miller TA, et al. Pregnancy loss in major fetal congenital heart disease: incidence, risk factors and timing. Ultrasound Obstet Gynecol. 2023. PMID: 37099500. doi:10.1002/uog.26231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。